Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

In this interview, Dr. Robert Beal discusses how advances in digital polymerase chain reaction technologies are reshaping ...

That’s the aim of predictive cyber resilience (PCR)—an emerging approach to security built on intelligence, automation and ...

Ampacet's AI system automatically corrects color variations in real time, improving quality and reducing waste in operations.

A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short reads” recently published in ...

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

Jammu Zone, Bhim Sen Tuti, today visited the District Police Lines (DPL) Jammu and District Police Control Room (PCR) Jammu ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

Roche’s cobas BV/CV assay gains CE Mark, enabling accurate, rapid diagnosis of bacterial vaginosis and candida vaginitis.

The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...

On this week’s “More To The Story,” activist Catherine Coleman Flowers examines how the Trump administration’s environmental ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...